A New Class of Cancer Drugs May Be Less Toxic

December 05, 2020

An experimental treatment, called T-DM1, is a harbinger of a new class of cancer drugs that may be more effective and less toxic than many existing treatments. These laboratory-produced molecules mimic the antibodies made by a person’s immune system to fight infection. But instead of attacking pathogens these antibodies attach to specific proteins on the surface of cancer cells. “It’s almost like we’re masking the chemotherapy,” said Dr. Edith Perez, a breast cancer specialist at the Mayo Clinic in Jacksonville, Fla. Read more at http://www.nytimes.com/2012/06/01/business/a-new-class-of-cancer-drugs-may-be-less-toxic.html?_r=2&smid=tw-nytimes&seid=auto



Also in News

Understanding Alcohol in Skincare. Not all alcohols are what you may think.

July 28, 2021

When we hear, "alcohol" most people think of rubbing alcohol (isopropyl) or alcoholic beverages (ethanol).  When employed in personal care products, it is often erroneously assumed that all alcohols are drying to the skin.

Read More

Eye melanoma risk factors

December 07, 2020

Read More

Some Women’s Preventive Services Now Covered Without Co-Payment

December 07, 2020

Read More